Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: Pathological correlations

British Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 503-509

  Gonzalez, R ^a   Silva, J M ^a   Dominguez, G ^a   Garcia, J M ^a   Martinez, G ^a   Vargas, J ^b   Provencio, M ^a   Espana P ^a   Bonilla, F ^a,c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^c Clinica del Trabajo   (Spain)

Author keywords

BRCA1; BRCA2; LOH; RAD51; RAD52; RAD54

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DOUBLE STRANDED DNA; ESTROGEN RECEPTOR; MICROSATELLITE DNA; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER STAGING; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 17Q; CHROMOSOME 1P; DNA RECOMBINATION; DNA REPAIR; FEMALE; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

AGE FACTORS; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA; CHROMOSOMES, HUMAN; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; FUNGAL PROTEINS; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; RAD51 RECOMBINASE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032837270     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690722     Document Type: Article

References (32)

1. Beckmann MW, Picard F, An HX, Van Rocyen CRC, Dominik SI, Mosny DS, Schnurch HG, Bender HG and Niederacher D (1996) Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220-1226
2. Benson FE, Stasiak A and West SC (1994) Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J 13: 5764-5771
3. Bièche I and Lidereau R (1995) Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227-251
4. Chapman MS and Verma IM (1996) Transcriptional activation by BRCA1. Nature 382: 678-679
5. Cleton Jansen A-M, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornclisse CJ and Stratlon MR (1995) Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosonic 13q12-q13. Br J Cancer 72: 1241-1244
6. Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VLJ and Ashworth A (1997) Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nature Genet 17: 423-430
7. Devilee P and Cornelisse C (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113-130
8. Ellis NA, Gioden J, Ye TZ, Stranghen J, Lennon DJ, Ciocci S, Proyteheva M and German J (1995) The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83: 655-666
9. Harris JR, Morrow M and Norton L (1997) Malignant tumors of the breast. In: DeVita VT, Hellman S and Rosemberg SA (eds) Cancer Principles and Practice of Oncology, Vol. 2, 5th edn, pp. 1557-1616. Lippincott-Noreu, Philadelphia
10. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jackernier J, Sobol H, Eisinger F and Birnbaum D (1997) Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 57: 5469-5474
11. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoof R, Collins N, Bignell G, Patel S, Hamoudi R, Larson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-240
12. Ludwig T, Chapman DL, Papaioannou VE and Efstratiadis A (1997) Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11: 1226-1241
13. Marmorstein LY, Ouchi T and Aaronson SA (1998) The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci USA 95: 13869-13874
14. Matson SW and Kaiser-Rogers KA (1990) DNA helicases. Annu Rev Biochem 59: 289-329
15. Milner J, Ponder B, Hughes-Davies L, Seltman M and Kouzarides T (1997) Transcriptional activation functions in BRCA2. Nature 386: 772-773
16. Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet 13: 245-247
17. Muris DAR, Bezzuvoba O, Buerstedde JM, Vreeken K, Balajee AS, Osgood CJ, Troelstra C, Hoeijmakers JHJ, Osterman K, Schmidt H, Natarajan AT, Ecken JCJ, Lohman PHM and Pastink A (1994) Cloning of human and mouse genes homologous to RAD52, a yeast gene involved in DNA repair and recombination. Mutation Res 315: 295-305
18. Oto M, Miyake S and Yuasa Y (1993) Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Ann Biochem 213: 19-22
19. Park MS (1995) Expression of human RAD52 confers resistance to ionizing radiation in mammalian cells. J Biol Chem 270: 15467-15470
20. Park MS, Ludwig DL, Stigger E and Lee S-H (1996) Physical interaction between human RAD52 and RPA is required for homologous recombination in mammalian cells. J Biol Chem 271: 18996-18200
21. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lidblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacious S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Devilee P and Larsson C (1998) Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res 58: 1004-1012
22. Rasio D, Murakumo Y, Robbins D, Roth T, Silver A, Negrini M, Schmidt C, Burczak J, Fishel R and Croce CM (1997) Characterization of the human homologue of RAD54: A gene located on chromosome 1p32 at a region of high loss of heterozygosity in breast tumors. Cancer Res 57: 2378-2383
23. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T and Livingston DM (1997) Association of BRCA1 with Rad51 in mitotic and J meiotic cells. Cell 88: 265-275
24. Sharan SK, Morimatsu M, Albrecht U, Lim D-S, Regel E, Dinh C, Sands A, Eichele G, Hasty P and Bradley A (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810
25. Shen Z, Cloud KJ, Chen DJ and Park MS (1996) Specific interaction between the human RAD51 and RAD52 proteins. J Biol Chem 271: 148-152
26. Shinohara A, Ogawa H, Matsuda Y, Ushio N, Ikeo K and Ogawa T (1993) Chining of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nature Genet 4: 239-243
27. WMRCIPI. Nature 389: 187-190
28. Stürzbecher RW, Donzehmann B, Henning W, Knippschild U and Buchhop S (1996) p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J 15: 1992-2002
29. Sung P, Bailly V, Weber C, Thompson LH Prakash L and Prakash S (1993) Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature 365: 852-855
30. Suzuki A, De La Pompa JL, Hakem R, Elia A, Yoshida R, Mo R, Nishina H, Chuang T, Wakeham A, Itie A, Koo W, Billia P, Ho A, Fukumoto M, Hui CC and Mak TW (1997) Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev 11: 1242-1252
31. Teng DH-F, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AKC and Kamb A (1996) Low incidence of BRCA2 imitations in breast carcinoma and other cancers. Nature Genet 13: 241-244
32. van der Berg J, Johannsson O, Hakansson S, Olsson H and Borg A (1996) Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74: 1615-1619